Our findings of recurrent mutations in KRAS/NRAS genes in 8.8% of the APL cases were slightly lower than the observation by others, and the mutations in FLT3 (43.3%) were similar to the previous studies (20–53%) (21, 33–35). Here, NRAS is linked to acute promyelocytic leukemia.